130 related articles for article (PubMed ID: 11908069)
21. Lactacystin, proteasome function, and cell fate.
Fenteany G; Schreiber SL
J Biol Chem; 1998 Apr; 273(15):8545-8. PubMed ID: 9535824
[No Abstract] [Full Text] [Related]
22. DUBs and disease: activity assays for inhibitor development.
Shanmugham A; Ovaa H
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):688-96. PubMed ID: 18729020
[TBL] [Abstract][Full Text] [Related]
23. Docking studies and model development of tea polyphenol proteasome inhibitors: applications to rational drug design.
Smith DM; Daniel KG; Wang Z; Guida WC; Chan TH; Dou QP
Proteins; 2004 Jan; 54(1):58-70. PubMed ID: 14705024
[TBL] [Abstract][Full Text] [Related]
24. Proteasome inhibitors: from in vitro uses to clinical trials.
Rivett AJ; Gardner RC
J Pept Sci; 2000 Sep; 6(9):478-88. PubMed ID: 11016885
[TBL] [Abstract][Full Text] [Related]
25. Targeting proteasome inhibition in hematologic malignancies.
Hideshima T; Richardson PG; Anderson KC
Rev Clin Exp Hematol; 2003 Jun; 7(2):191-204. PubMed ID: 14763162
[TBL] [Abstract][Full Text] [Related]
26. Proteasomal degradation of tau protein.
David DC; Layfield R; Serpell L; Narain Y; Goedert M; Spillantini MG
J Neurochem; 2002 Oct; 83(1):176-85. PubMed ID: 12358741
[TBL] [Abstract][Full Text] [Related]
27. Proteolytic activity in intact sheets of polarized epithelial cells as determined by a cell-permeable fluorogenic substrate.
Karlsson JO; Lundquist J; Skoglund I; Nilsson M
Cell Biol Int; 2000; 24(4):235-43. PubMed ID: 10816325
[TBL] [Abstract][Full Text] [Related]
28. Lactacystin augments the sulindac-induced apoptosis in HT-29 cells.
Choi HJ; Kim HH; Lee HS; Huh GY; Seo SY; Jeong JH; Kim JM; Yoo YH
Apoptosis; 2003 Jun; 8(3):301-5. PubMed ID: 12766490
[TBL] [Abstract][Full Text] [Related]
29. Synthetic inhibitors of the multicatalytic proteinase complex (proteasome).
Wilk S; Figueiredo-Pereira ME
Enzyme Protein; 1993; 47(4-6):306-13. PubMed ID: 7697128
[TBL] [Abstract][Full Text] [Related]
30. Chemistry in living cells: detection of active proteasomes by a two-step labeling strategy.
Ovaa H; van Swieten PF; Kessler BM; Leeuwenburgh MA; Fiebiger E; van den Nieuwendijk AM; Galardy PJ; van der Marel GA; Ploegh HL; Overkleeft HS
Angew Chem Int Ed Engl; 2003 Aug; 42(31):3626-9. PubMed ID: 12916032
[No Abstract] [Full Text] [Related]
31. Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin beta-lactone.
Dick LR; Cruikshank AA; Grenier L; Melandri FD; Nunes SL; Stein RL
J Biol Chem; 1996 Mar; 271(13):7273-6. PubMed ID: 8631740
[TBL] [Abstract][Full Text] [Related]
32. Preservation of caspase-3 subunits from degradation contributes to apoptosis evoked by lactacystin: any single lysine or lysine pair of the small subunit is sufficient for ubiquitination.
Chen L; Smith L; Wang Z; Smith JB
Mol Pharmacol; 2003 Aug; 64(2):334-45. PubMed ID: 12869638
[TBL] [Abstract][Full Text] [Related]
33. Proteasome activity is required for the stage-specific transformation of a protozoan parasite.
González J; Ramalho-Pinto FJ; Frevert U; Ghiso J; Tomlinson S; Scharfstein J; Corey EJ; Nussenzweig V
J Exp Med; 1996 Nov; 184(5):1909-18. PubMed ID: 8920878
[TBL] [Abstract][Full Text] [Related]
34. In vitro effects of gliotoxin, a natural proteasome inhibitor, on the infectivity and proteolytic activity of Toxoplasma gondii.
Paugam A; Creuzet C; Dupouy-Camet J; Roisin P
Parasitol Res; 2002 Aug; 88(8):785-7. PubMed ID: 12122440
[TBL] [Abstract][Full Text] [Related]
35. The Leishmania chagasi proteasome: role in promastigotes growth and amastigotes survival within murine macrophages.
Silva-Jardim I; Horta MF; Ramalho-Pinto FJ
Acta Trop; 2004 Jul; 91(2):121-30. PubMed ID: 15234661
[TBL] [Abstract][Full Text] [Related]
36. Requirement of the proteasome for the trimming of signal peptide-derived epitopes presented by the nonclassical major histocompatibility complex class I molecule HLA-E.
Bland FA; Lemberg MK; McMichael AJ; Martoglio B; Braud VM
J Biol Chem; 2003 Sep; 278(36):33747-52. PubMed ID: 12821659
[TBL] [Abstract][Full Text] [Related]
37. Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy.
Abu-Baker A; Messaed C; Laganiere J; Gaspar C; Brais B; Rouleau GA
Hum Mol Genet; 2003 Oct; 12(20):2609-23. PubMed ID: 12944420
[TBL] [Abstract][Full Text] [Related]
38. Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide alpha',beta'-epoxyketones.
Elofsson M; Splittgerber U; Myung J; Mohan R; Crews CM
Chem Biol; 1999 Nov; 6(11):811-22. PubMed ID: 10574782
[TBL] [Abstract][Full Text] [Related]
39. Effects of proteasome inhibitors on the synaptic localization of Vesl-1S/Homer-1a proteins.
Ageta H; Kato A; Fukazawa Y; Inokuchi K; Sugiyama H
Brain Res Mol Brain Res; 2001 Dec; 97(2):186-9. PubMed ID: 11750075
[TBL] [Abstract][Full Text] [Related]
40. [Lactacystin: a tool for elucidation of proteasome functions].
Omura S; Takeshima H
Tanpakushitsu Kakusan Koso; 1996 Apr; 41(4):327-36. PubMed ID: 8721375
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
